Hematospermia-the added value of transrectal ultrasound to clinical evaluation: Is transrectal ultrasound necessary for evaluation of hematospermia?

Gil Raviv; Menachem Laufer; Haifler Miki

doi:10.1016/j.clinimag.2013.05.007

Hematospermia-the added value of transrectal ultrasound to clinical evaluation: Is transrectal ultrasound necessary for evaluation of hematospermia?

Gil Raviv, Menachem Laufer, Haifler Miki^*

^*Corresponding author for this work

Surgery

Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Hematospermia is usually caused by nonspecific inflammation of the prostate and seminal vesicles. Transrectal ultrasound (TRUS) is a safe and inexpensive modality for evaluating patients with hematospermia. The aim of this study is to describe the findings of TRUS and its contribution to patients' management.A total of 115 consecutive patients presented with hematospermia and evaluated with TRUS between 2006 and 2012.All patients exhibited an abnormality in the TRUS examination. A 12-core TRUS-guided biopsy of the prostate was taken from 10 patients, but none of these samples were positive for tumor.In the vast majority of cases, a benign cause can be identified using TRUS. These causes usually do not require treatment.

Original language	English
Pages (from-to)	913-916
Number of pages	4
Journal	Clinical Imaging
Volume	37
Issue number	5
DOIs	https://doi.org/10.1016/j.clinimag.2013.05.007
State	Published - Sep 2013

Keywords

Hematospermia
Prostate
Seminal vesicle
Transrectal ultrasound

Access to Document

10.1016/j.clinimag.2013.05.007

Cite this

@article{e4f6cbdddfb4437e9442ee4c7196ab7b,

title = "Hematospermia-the added value of transrectal ultrasound to clinical evaluation: Is transrectal ultrasound necessary for evaluation of hematospermia?",

abstract = "Hematospermia is usually caused by nonspecific inflammation of the prostate and seminal vesicles. Transrectal ultrasound (TRUS) is a safe and inexpensive modality for evaluating patients with hematospermia. The aim of this study is to describe the findings of TRUS and its contribution to patients' management.A total of 115 consecutive patients presented with hematospermia and evaluated with TRUS between 2006 and 2012.All patients exhibited an abnormality in the TRUS examination. A 12-core TRUS-guided biopsy of the prostate was taken from 10 patients, but none of these samples were positive for tumor.In the vast majority of cases, a benign cause can be identified using TRUS. These causes usually do not require treatment.",

keywords = "Hematospermia, Prostate, Seminal vesicle, Transrectal ultrasound",

author = "Gil Raviv and Menachem Laufer and Haifler Miki",

year = "2013",

month = sep,

doi = "10.1016/j.clinimag.2013.05.007",

language = "אנגלית",

volume = "37",

pages = "913--916",

journal = "Clinical Imaging",

issn = "0899-7071",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Hematospermia-the added value of transrectal ultrasound to clinical evaluation

T2 - Is transrectal ultrasound necessary for evaluation of hematospermia?

AU - Raviv, Gil

AU - Laufer, Menachem

AU - Miki, Haifler

PY - 2013/9

Y1 - 2013/9

N2 - Hematospermia is usually caused by nonspecific inflammation of the prostate and seminal vesicles. Transrectal ultrasound (TRUS) is a safe and inexpensive modality for evaluating patients with hematospermia. The aim of this study is to describe the findings of TRUS and its contribution to patients' management.A total of 115 consecutive patients presented with hematospermia and evaluated with TRUS between 2006 and 2012.All patients exhibited an abnormality in the TRUS examination. A 12-core TRUS-guided biopsy of the prostate was taken from 10 patients, but none of these samples were positive for tumor.In the vast majority of cases, a benign cause can be identified using TRUS. These causes usually do not require treatment.

AB - Hematospermia is usually caused by nonspecific inflammation of the prostate and seminal vesicles. Transrectal ultrasound (TRUS) is a safe and inexpensive modality for evaluating patients with hematospermia. The aim of this study is to describe the findings of TRUS and its contribution to patients' management.A total of 115 consecutive patients presented with hematospermia and evaluated with TRUS between 2006 and 2012.All patients exhibited an abnormality in the TRUS examination. A 12-core TRUS-guided biopsy of the prostate was taken from 10 patients, but none of these samples were positive for tumor.In the vast majority of cases, a benign cause can be identified using TRUS. These causes usually do not require treatment.

KW - Hematospermia

KW - Prostate

KW - Seminal vesicle

KW - Transrectal ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84883657121&partnerID=8YFLogxK

U2 - 10.1016/j.clinimag.2013.05.007

DO - 10.1016/j.clinimag.2013.05.007

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 23845256

AN - SCOPUS:84883657121

SN - 0899-7071

VL - 37

SP - 913

EP - 916

JO - Clinical Imaging

JF - Clinical Imaging

IS - 5

ER -

Hematospermia-the added value of transrectal ultrasound to clinical evaluation: Is transrectal ultrasound necessary for evaluation of hematospermia?

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this